<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Carie Health Inc.

    Carie Health Inc.

    Carie Health is a mobile healthcare solution that allows members to connect with a...

    Carie Health is a mobile healthcare solution th...

    Amount Raised:    $7,000,000
    Fundraising Status:    SA
    Filing Type:    CF
    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused ...

    DiaMedica Therapeutics Inc. is a clinical stage...

    Filing Type:    PU
    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused o...

    BioXcel Therapeutics, Inc. is a clinical stage ...

    Filing Type:    PU
    Menlo Therapeutics Inc.

    Menlo Therapeutics Inc.

    We are a late stage biopharmaceutical company focused on the development and comme...

    We are a late stage biopharmaceutical company f...

    Filing Type:    PU
    Altimmune, Inc.

    Altimmune, Inc.

    Altimmune is a clinical-stage immunotherapeutics company focused on the developmen...

    Altimmune is a clinical-stage immunotherapeutic...

    Filing Type:    PU
    Theratechnologies Inc.

    Theratechnologies Inc.

    Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet...

    Theratechnologies (TSX: TH) is a specialty phar...

    Filing Type:    PU
    Castle Biosciences, Inc.

    Castle Biosciences, Inc.

    Castle Biosciences is a skin cancer diagnostics company focused on providing physi...

    Castle Biosciences is a skin cancer diagnostics...

    Filing Type:    PU
    Arvinas, Inc.

    Arvinas, Inc.

    Arvinas is a biopharmaceutical company dedicated to improving the lives of patient...

    Arvinas is a biopharmaceutical company dedicate...

    Filing Type:    PU
    Genprex, Inc.

    Genprex, Inc.

    Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in ...

    Genprex Inc is a U.S.-based clinical-stage gene...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.